The fetal mouse omentum has been shown to be a source of precursors that exclusively reconstitutes Lyl + B cells and the closely related Lyl-sister population, but not conventional B cells or T cells. We have extended these studies to compare B cell development in the human fetal omentum, liver, and spleen, and to demonstrate that the pro/pre-B cell compartment (CD24 +, sIgM-) is detected in the omentum and liver but not spleen as early as 8 wk of gestation. From 8 to 12 wk of gestation, the proportions of IgM + cells that were pre-B cells (cIgM + AIgM-) in the omentum and liver were 53 _+ 15% and 45 _+ 13%, respectively, and IgM § cells were not detectable in the spleen. After 12 wk, the percentage of pre-B cells was unchanged in the fetal liver (41 _+ 10%) but decreased significantly in the omentum (25 • 14%); pre-B cells were now detected in the spleen but at much lower percentages (2 • 3%) than either the omentum or liver. The nuclear enzyme, Tdt, was detected in approximately 25% of the CD24 + cells in the omentum and liver during the 8-12-wk time period, however, Tdt + cells were not detected in the spleen. Approximately 40% of the mature B cells found in the omentum and spleen were CD5 § compared with only 20% in the liver. These results demonstrate that the fetal omentum, like the fetal liver and bone marrow, is a primary site of B cell development.
T he mouse fetal liver is an early site of hematopoiesis and a rich source of stem cells capable of reconstituting all hematopoietic lineages including Lyl + B cells (1, 2) . At 16-17 d of gestation, hematopoiesis begins to shift from the liver to the bone marrow where it is maintained throughout adult life (3) . However, adult bone marrow, in contrast to fetal liver, only poorly reconstitutes Lyl + B cells, which has led to the suggestion that Lyl B cells were derived from distinct precursors that are present in the fetus but absent in the adult (2) . More recently, it has been shown that mouse B cell precursors from fetal liver give rise in vitro and in vivo to CD5 + B cells, whereas bone marrow precursors with the same phenotype give rise only to conventional B cells (4) . In this connection we have recently demonstrated that the fetal mouse omentum contains precursors that give rise exclusively to Lyl + B cells and the closely related Lyl-sister population but not conventional B cells or T cells (5) . These findings raise the possibility that very early during development Lyl + B cells are generated in a compartment distinct from that for conventional B cells.
Lyl + B cells differ from conventional B cells in their surface phenotype, tissue localization, and immunoglobulin repertoire (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) . The most intriguing characteristic of Lyl + B cells in mice and CD5 + (human Lyl homologue) B cells in humans is the production of antibodies with affinity for selfantigens. Many antibody specificities, including rheumatoid factor activity, anti-DNA, and anti-T cell reactivity, appear to be enriched in this B cell subset (9) (10) (11) (12) . The best studied reactivity of these B cells in mice is the in vitro affinity for bromelain-treated mouse red blood cells (13) . The overrepresentation of this specificity within Lyl + B cells is clearly the result of antigen selection, however, the mechanism for the segregation of this antibody specificity or the nature of its physiological counterpart in vivo is unclear (14, 15) . Although there is an association between increased levels of CD5 + B cells in certain autoimmune diseases such as rheumatoid arthritis in humans and in the autoimmune NZB mice (6, 16) , CD5 + B cells have not been shown to secrete pathogenic autoantibodies, and the exact role they play in the etiology of autoimmune disease is not known.
The human fetal liver is also an early site of hematopoiesis (17) . Pre-B cells (clgM+AIgM -) are first detectable in human fetal life at 0,8 wk of gestation, and it is not until o,12 wk that peripheralization of B cells occurs (18) . A report from Bofill et al. (19) using immunohistochemical techniques described the appearance of CD5 B cells in the human fetal peritoneal and pleural cavity at 15 wk of gestation, however, these cells were absent from the liver before 16 wk and were rare in the bone marrow. This led the authors to comment that the "original derivation of these cells is a mystery"
Since the mouse omentum has been shown to be a source of precursors for Lyl + B cells, we have compared B cell development in the human fetal omentum, liver, and spleen.
In this report, we demonstrate that B cell development occurs simultaneously in situ in the human fetal liver and omentum but not spleen, and that B cells from the omentum showed a bias towards CD5 expression.
Materials and Methods
Fetal Samples. Fetal liver, spleen, and omentum were obtained from elective abortion samples received from The Central Laboratory for Human Embryology, University of Washington (Seattle, WA), and gestational age was estimated by foot length.
Preparation of Single Cell Suspensions. The fetal liver, omentum, and spleen were dissected and placed in 1 ml of a 50% solution of Dispase II (Boehringer Mannheim Biochemicals, Indianapolis, IN) in complete RPMI with 5% FCS. The samples were placed in Eppendorf tubes and put on an orbital shaker (Fisher Scientific Co., Pittsburgh, PA), at speed 400 for 1 h at 37~ The single cell suspensions were then centrifuged and washed two times in complete KPMI (Gibco Laboratories, Grand Island, NY) with 10% FCS and stained for flow cytometry as described below.
Antibodies. mAbs against CD5 and CDllb were purchased from Becton Dickinson & Co. (Mountain View, CA). The anti-CD24 (IgM, g) mAb, BA-1 (20) , was provided by Dr. Tucker Lebien (University of Minnesota), and the anti-CD24 (IgG1, K) mAb, SN3, was provided by Dr. Ben Seon (Roswell Park Cancer Center). The anti-CD45RO antibody, HB11, has been described previously (21) . The goat anti-mouse IgGI-PE, anti-mouse IgG-biotin, anti-human IgM-FITC, and anti-human IgM-ILITC antibodies were purchased from Southern Biotechnology Associates (Birmingham, AL). The FITC and RITC anti-human IgM antibodies were extensively absorbed on mouse Ig coupled to Sepharose 4B before use. The antiTdt antibody was purchased from Supertechs (Bethesda, MD).
Immunofluorescence Staining. The protocol for staining pre-B ceils and mature B cells has been described elsewhere (22) . We also added 1 #1 of I rag/m1 Hoescht dye to 250 ml of the final PBS wash to facilitate counting of nucleated cells. To quantitate the percentage of cells with phenotypes described in Fig. 4 , three aliquots of cells were stained with anti-CD24 (IgM, K) followed by anti-mouse IgM-FITC. Cytocentrifuge preparations were made and fixed in methanol for 20 rain. One slide was then stained with anti-human IgM-P, ITC to allow calculation of the percentage of the IgM +/CD24 + cells. The second slide was stained with anti-Tdt followed by anti-mouse IgG biotin and finally Streptavidin-Texas red (SATR) t for calculation of the percentage of Tdt +/CD24 + cells. To calculate the percentage of Tdt-/IgM-/CD24 + cells, the last slide was stained with anti-Tdt, then anti-mouse IgG biotin followed by SATR, and finally the anti-human IgM-RITC.
For flow cytometric analysis, cells were stained with the antibodies indicated in the text using the following regimen. Cells were stained in a 96-well round-bottomed plate. 10 #1 of the appropriate antibody was added for 10 rain on ice and the cells were washed once with 200 #1 of PBS/FCS followed by the next antibody as indicated. The samples were fixed in 1% paraformaldehyde (pH 7.4) and analyzed on a FACScan | (Becton Dickinson & Co.).
Immunohistochemicat Analysis of Tissu~ To detect IgM § cells in the fetal omentum, this tissue was embedded in paraffin, sectioned 1Abbreviations used in this paper: c, cytoplasmic; s, surface; SATR, Streptavidin-Texas red.
and processed for immunofluorescence staining as previously described (23) . The sections were stained with goat anti-human IgM-FITC. Serial sections were also stained with hematoxylin and eosin (H&E).
Results

Histology of the Human Fetal Omentum.
A photomicrograph of 10-wk-old human fetal omentum and spleen is shown in Fig. 1 A. During fetal life, the omentum is a thin transparent well vascularized membrane with clusters of erythrocytes associated with the vasculature (Fig. 1 B) . Immunofluorescent staining using FITC-conjugated anti-human IgM showed that B lineage cells could be detected along the periphery of these erythroid areas (Fig. 1 C) . B cells were also found in loose loci or as isolated cells throughout the mesentery without any association with the vasculature.
The (Fig. 3) . In the fetal omentum and liver, the percentage ofpre-B cells was 53 + 15 and 45 _+ 13, respectively, while B lineage cells were undetectable in the spleen during this time period. After the 8-12-wk period, the percentage of pre-B cells was unchanged in the fetal liver (41 +_ 10) but was significantly lower in the omentum (25 _+ 14) .
These results may indicate that the development of B cells in the fetal omentum is transitory, however, we cannot rule out the possibility that the pre-B cells are simply being diluted by mature B cells seeding to the periphery during this time period. Analysis of fetal omentum from the last trimester is needed to address this question, however, fetal tissue from these late gestational ages are not available. Beginning at '~12 wk, pre-B cells were detected in the spleen (2 +_ 3) but at much lower percentages than either the liver or omentum.
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Solvason and Kearney A variety of antibodies against other B cell surface markers were used in an attempt to determine if (1) the CD5-B cells in the omentum were the CD5-"sister" population and (2) omental B cells could be further distinguished from those in the fetal liver. Mac-1 is expressed on mouse CD5 + B cells as well as the CDS-sister population but not on conventional B cells. However, <0.1% of the slgM + B cells in either the omentum or liver expressed CDllb, the human analogue of Mac-1. In addition, there were no differences in the ratios of intensity of IgM and IgD expression by B cells in the omentum vs. liver. CD45RO, detected by mAb HBll, was expressed on the B cells from the omentum at a 20% higher level than B cells from the fetal liver (n = 3) (data not shown). Thus, using the available markers, we have been unable to determine if, in addition to the higher frequency of CD5 B cells present in the omentum, they are homogeneously distinct from those in the fetal liver.
As can be seen in both omentum and spleen, relatively large numbers of CD5 + T cells were detected (UL quadrant) which were absent or rare in the fetal liver. The T cells found in the omentum and spleen expressed either c~/~ or ~,/6 TCRs in a ratio that indicated that they were most likely mature T cells which at this time have migrated to the periphery.
Analysis of Pro/Pre-B Cells for the Presence of the CD5 Antigen.
Three-color flow cytometry was used to determine when the CD5 antigen first appeared during development of B cells. Analysis gates were set to analyze exclusively B lineage cells using CD24 as a pan-B cell marker in conjunction with anti-IgM FITC and CD5-PE; the pro/pre-B cells (slgM-) (Fig. 6 A) and the mature B cells (slgM +) (Fig.  6 B) were analyzed separately for the expression of the CD5 antigen. The cells in the pro/pre-B cell compartment failed to express CDS, while it was easily detected on slgM + B cells.
Discussion
The human perinatal and adult omentum is considered part of the lymphoid system because it contains loose unorganized lymphoid aggregates called "milk spots" (29) . Despite its activity as a secondary lymphoid organ, there has been no analysis of the fetal omentum with respect to the generation of lymphocytes in situ in development or in the adult. In this study we show that the pro/pre-B cell compartment (CD24 + / slgM-), pre-B cells (clgM +/slgM-), and Tdt + B lineage ceils can be detected as early as 8 wk of gestation in the human fetal omentum. These results demonstrate that B cell generation occurs in situ in the human fetal omentum concomitant with that occurring in the fetal liver.
Pro/pre-B cells were detected as early as 8 wk of gestation in the fetal omentum at a time when the pro/pre-B:mature B cell ratio is similar in the omentum and liver. In contrast, this compartment of the B cell lineage was not detected in the spleen until ~12 wk of gestation. In addition, the percentage of pre-B/IgM + cells in the fetal omentum and liver was approximately the same during the early 8-12-wk time period. However, during the 13-23-wk period, the percentage of pre-B cells/IgM + cells decreased significantly in the omentum, while remaining at the same level in the liver. These results are consistent with the idea that the development of B cells in the omentum is transitory, however, analysis of fetal omentum from later gestational ages is needed to determine the length of time that the fetal omentum maintains the ability to generate B lineage ceils in situ. Additionally, during the 13-23-wk time period, pre-B cells became detectable in the spleen but at a much lower frequency than that seen in either the liver or omentum.
Tdt + cells have been detected in the fetal liver as early as 7 wk of gestation (30) and are believed to represent a stage of B cell development during which gene rearrangements occur (25) (26) (27) . Here we report that ~25% of the CD24 + cells in both the fetal omentum and liver from 8-12 wk of gestation express the nuclear antigen Tdt. Interestingly, almost 30% of the CD24 + cells present in both tissues during the time period are negative for Tdt and IgM. This population was not described in a report from Nishimoto et al. (28) in analysis of CD19 + B lineage cells from fetal bone marrow. This may reflect the presence of the CD24 antigen on B lineage cells at a more immature stage than CD19. Alternatively, this population may represent the earliest B lineage cells, and are present in large enough numbers to be detected only during very early gestation in fetal liver and omentum but not in later fetal bone marrow.
These results clearly demonstrate that every identifiable stage in B cell differentiation is detected in both the fetal omentum and liver as early as 8 wk of gestational age. This is in contrast to the fetal spleen, a peripheral secondary lymphoid organ, where little B cell generation appears to occur in humans and very few ceils of immature phenotype are detected at any stage of development. The presence of B cell progenitors in liver and omentum at a time when they are undetectable in spleen also argues against the origin of these cell types in either organ as blood-borne contaminants.
Examination of mature B cells demonstrated a higher percentage of CD5 + B cells in the omentum and spleen compared with the fetal liver. However, in the human fetal omentum and spleen, >50% of the B ceils were CD5-, similar to our results obtained by reconstitution of scid mice with fetal mouse omentum (5) . In mice, the closely related Lyl-sister population is well characterized, and we were able to identify the Lyl-B cells as the sister population. Since, at the moment, there are no useful phenotypic markers to distinguish the CD5-sister population from conventional B cells in humans, we cannot determine whether the CD5-B cells present in the human omentum are equivalent to the CD5-sister population.
Although we have proposed that the mouse fetal omentum may provide a unique milieu that directs immature cells along the CD5 B cell lineage, there is evidence that CD5 B cell generation may be a general property of fetal B lineage differentiation (4). Our results, although suggestive that the omentum may constitute an enriched source of CD5 cells, obviously needs further comparative data with respect to differentiation antigen and V region usage by the B cell populations from liver and omentum. There is an alternative hypothesis related to CD5 B cell development proposed by Conget al. (31) , which suggests that crosslinking of slgM on newly emerging B cells stimulates the expression of the Lyl antigen. Although our results do not directly support this hypothesis, we have clearly shown that the CD5 antigen does not appear until or after the expression of slgM. This is in contrast to CD5 expression by human and mouse T cells, which occurs early in thymocytes before TCR expression (32, 33) . The contemporaneous expression of CD5 with slgM during development of B cells suggests that the expression of both surface proteins may be linked.
Our earlier work in mice (5) and this report in humans show that the fetal omentum is a site where B cells are generated, thus raising the question as to the significance of the fetal omentum in B cell development in other species. B cell development as judged by the presence of pre-B cells also occurs in the fetal omentum in rabbits (our unpublished data). At this point we do not know if the B cells generated in the fetal rabbit omentum express the CD5 antigen. However, this observation, in addition to the work presented here and our previous work with fetal mouse omentum, demonstrates that this site is conserved through evolution in a variety of mammals as a site of B cell generation and should be considered along with the fetal liver, thymus, and bone marrow as a primary lymphoid organ during the development of the immune system.
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